Delivery Order SPE2DB20D3103-SPE2DB25FM5N2

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,340.65 firm fixed-price delivery order is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,250.23 firm-fixed-price delivery order is for the procurement of OPZELURA 1.5% cream, a prescription pharmaceutical product. The award has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,187.36 firm fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, with a period of performance through January 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $4,557.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of OPZELURA 1.5% cream, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 24, 2024, and is structured as a firm fixed-price agreement. The award is not associated with a set-aside designation, indicating open...
This federal contract award, valued at $5,727.11, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Opzelura 1.5% cream, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026, which covers a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,078.49 firm fixed price delivery order is for OPZELURA 1.5% Cream, a 60 gram prescription medication. The contract has an ultimate completion date of December 3, 2024 and does not utilize a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,756.15 delivery order is for OPZELURA 1.5% CREAM 60GM, a medical supply product. The contract is a firm fixed-price delivery order with an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the U.S. Department of Defense's Medical Supply Chain agency to Amerisourcebergen Drug Corporation's Corporate Office division. The $2,664.24 Firm Fixed Price Delivery Order is for the supply of OPZELURA 1.5% Cream in 60g tubes, with a performance period ending on July 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical to...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides a delivery order for the supply of OPZELURA 1.5% cream, a pharmaceutical product. The $6,030.14 contract is a firm fixed-price delivery order, with no set-aside designation, issued by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,086.16 fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product. The contract has a period of performance through November 7, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM5N2
    Delivery Order

This federal contract award, valued at $7,703.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of OPZELURA 1.5% Cream in 60-gram units, with a completion date of February 4, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside requirements indicated.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/5/25, 9:48 AM